Effect of amphetamine on behavioral patterns of obsessive-compulsive and addictive gambling in a rat marble test

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access


A rodent marble test can be qualified as the most informative test of evaluation of obsessive-compulsive disorder as a neurobiological component of pathological gambling. Several behavioral components of obsession (obsessive and anxious ideas) and compulsions (obsessive actions) directed to anxiety reduction are modeled in this test. The effect of psychostimulant amphetamine on the rat behavior was studied in a marble test, anxiety-phobic model (scale), open field (evaluation of motor and emotional activity) and resident-intruder test (Intraspecies behavior). Amphetamine 0.5 and 1.5 mg/kg increased a number of burying bolls and elevated anxiety level in dose dependent manner. This accompanied with reduction of explorative activity, elevation of motor activity and number of individual behavioral patterns. Therefore, dopaminergic system of the brain activated with amphetamine is involved in obsessive-compulsive behavior and pathological gambling.

Full Text

Restricted Access

About the authors

Petr D. Shabanov

Institute of Experimental Medicine

Author for correspondence.
Email: pdshabanov@mail.ru
PhD, Professor Russian Federation

Andrei A. Lebedev

Institute of Experimental Medicine

Email: aalebedev-iem@rambler.ru
PhD, Leading Researcher Russian Federation

Natalia D. Yakushina

Institute of Experimental Medicine

Email: pdshabanov@mail.ru
Post-graduate Student Russian Federation

Anna G. Pshenichnaya

Institute of Experimental Medicine

Email: pdshabanov@mail.ru
Researcher Russian Federation

Eugenii R. Bychkov

Institute of Experimental Medicine

Email: pdshabanov@mail.ru
PhD Russian Federation


  1. Родина В.И., Крупина Н.А., Крыжановский Г.Н., и др. Многопараметровый метод комплексной оценки тревожно-фобических состояний у крыс // Журн. высш. нерв. деят. — 1993. — Т. 43. — № 5. — С. 1006–1017. [Rodina VI, Krupina NA, Kryizhanovskiy GN, et al. Mnogoparametrovyii metod kompleksnoi otsenki trevozhno-fobicheskih sostoyaniy u kryis. Zhurnal vysshei nervnoi deyatel’nosti imeni I.P. Pavlova. 1993;43(5):1006-1017. (In Russ).].
  2. Шабанов П.Д., Лебедев А.А., Русановский В.В., и др. Поведенческие эффекты кортиколиберина и его аналогов, вводимых в желудочки мозга крыс // Мед. акад. журнал. — 2005. — Т. 5. — № 3. — С. 59–67. [Shabanov PD, Lebedev AA, Rusanovskii VV. Povedencheskie effektyi kortikoliberina i ego analogov, vvodimyih v zheludochki mozga krys. Meditsinskiy akademicheskiy zhurnal.2005;5(3):59-67. (In Russ).].
  3. Шабанов П.Д., Лебедев А.А., Воеводин Е.Е., и др. Блокада рецепторов кортиколиберина в миндалине астрессином устраняет подкрепляющие эффекты фенамина, морфина и лей-энкефалина на самостимуляцию мозга // Эксперим. и клин. фармакология. — 2006. — Т. 69. — № 3. — С. 14–18. [Shabanov PD, Lebedev AA, Voevodin EE, et al. Astressin blockade of amygdaloid corticoliberin receptors eliminates the stimulating effects of amphetamine, morphine and leu-enkephalin on brain self-stimulation. Russian Journal of Experimental and Clinical Pharmacology. 2006;69(3):14-18. (In Russ).].
  4. Шабанов П.Д., Лебедев А.А., Павленко В.П. Влияние пептидов, вводимых в центральное ядро миндалины у крыс при хронической алкоголизации // Эксперим. и клин. фармакология. —2006. — Т. 69. — № 5. — С. 44–49. [Shabanov PD, Lebedev AA, Pavlenko VP, et al. Effect of peptides introduced into the central nucleus of amygdala on the hypothalamic self-stimulation in chronically alcoholized rats. Russian Journal of Experimental and Clinical Pharmacology. 2006;69(5):44-49. (In Russ).].
  5. Шабанов П.Д., Лебедев А.А. Угнетение самостимуляции латерального гипоталамуса опиатами и опиоидами, вводимыми в центральное ядро миндалины у крыс // Рос. физиол. журн. им. И.М. Сеченова. — 2011. — Т. 97. — № 2. — С. 180–188. [Shabanov PD, Lebedev AA. The extended amygdala system and self-stimulation of the lateral hypothalamus in rats: modulation with opiates and opioids. Neuroscience and Behavioral Physiology. 2011;97(2):180-188. (In Russ).].
  6. Albelda N, Joel D. Current animal models of obsessive compulsive disorder: an update. Neuroscience. 2012; 211:83-106. doi: 10.1016/j.neuroscience.2011.08.070.
  7. Blampied NM, Kirk RC. Defensive burying: effects of diazepam and oxprenolol measured in extinction. Life Sci. 1983;33(8):695-699. doi: 10.1016/0024-3205(83)90773-7.
  8. Boileau I, Payer D, Chugani B, et al. In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling:a positron emission tomography study with[C]-(+)-PHNO. Mol Psychiatry. 2014;10:1038-1063. doi: 10.1038/mp.2013.163.
  9. Bullock SA, Potenza MN. Pathological gambling: neuropsychopharmacology and treatment. Cur Psychophar-
  10. macol. 2012;1(1):67-85. doi: 10.2174/2211556011201010067.
  11. Craft RM, Howard JL, Pollard GT. Conditioned defensive burying as a model for identifying anxiolytics. Pharmacol. Biochem Behav. 1988;30(3):775-780. doi: 10.1016/0091-3057(88)90098-6.
  12. Cunningham-Williams RM, Cottler LB, Compton WM, et al.
  13. Taking chances: problem gamblers and mental health disorders: results from the St Epidemiologic Catchment Area Study. Am J Public Health. 1998;88(7):1093-1096. doi: 10.2105/AJPH.88.7.1093.
  14. Decloedt EH, Stein DJ. Current trends in drug treatment of obsessive–compulsive disorder. Neuropsychiatr Dis Treat. 2010;6:233-42. doi: 10.2147/NDT.S3149.
  15. Hayashi E, Kuratani K, Kinoshita M, Hara H. Pharmacological distinctive behaviors other than burying marble during the marble burying test in mice. J Pharmacology. 2010;86: 293-296. doi: 10.1159/000321190.
  16. Hollander E, Wong CM. Obsessive-compulsive spectrum disorders. J Clin Psychiatry. 1995;56(Suppl 4):3-6.
  17. Joel D. Current animal models of obsessive compulsive disorder: a critical review. Prog Neuropsychopharmacol Biol Psychiatry. 2006;3 (3):374-388. doi: 10.1016/j.pnpbp.2005.11.006.
  18. Leeman RF, Potenza MN. Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity. Psychopharmacology (Berl). 2012;219(2):469-490.
  19. doi: 10.1007/s00213-011-2550-7.
  20. Kalinina T, Kudryashov N, Naplekova P, et al. Interaction of antidepressants with mild chronic stress: behavioural effects and content of monoamines and their metabolites in mouse brain. Eur Neuropsychopharmacol. 2014;24:288. doi: 10.1016/S0924-977X(14)70455-9
  21. Koob GF. Dynamics of neuronal circuits in addiction: reward, antireward and emotional memory. Pharmacopsychiatry. 2009;42(10):32-41. doi: 10.1055/s-0029-1216356.
  22. Marazziti D, Carlini M, Dell’Osso L. Treatment strategies of obsessive-compulsive disorder and panic disorder/agoraphobia. Curr Top Med Chem. 2012;12(4):238-253. doi: 10.2174/1568026799078688.
  23. Millan MJ, Dekeyne A, Papp MJ, et al. S33005, a novel ligand at both serotonin and norepinephrine transporters. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. Pharmacol Exp Ther. 2001;298:581-591.
  24. Moy SS, Nonneman RJ, Shafer GO, et al. Disruption of social approach by MK-801 amphetamine, and fluoxetine in adolescent C57BL/6J mice. Neurotoxicol Teratol. 2013; 36:36-46. doi: 10.1016/j.ntt.2012.07.007.
  25. Naumenko VS, Bazovkina DV, Semenova AA, et al. Effect of glial cell line- derived neurotrophic factor on behavior and key members of the brain serotonin system in mouse strains genetically predisposed to behavioral disorders. J Neurosci Res. 2013;91(12):1628-1638. doi: 10.1002/jnr.23286.
  26. Nicolas LB, Kolb Y, Prinssen EP. A combined marble burying — locomotor activity test in mice: a practical screening test with sensitivity to different classes of anxiolytics and antidepressants. Eur J Pharmacol. 2006; 547(1-3):106-115. doi: 10.1016/j.ejphar.2006.07.015.
  27. Petry NM. Should the scope of addictive behaviors be broadened to include pathological gambling? Addiction. 2006;101(Suppl 1):152-160. doi: 10.1111/j.1360-0443.2006.01593.x.
  28. Potenza MN. Impulsivity and compulsivity in pathological gambling and obsessive-compulsive disorder. Rev Bras Psiquiatr. 2007;29(2):105-106. doi: 10.1590/S1516-44462007000200004.
  29. Potenza MN. Should addictive disorders include non-substance-related conditions? Addiction. 2006;101 (Suppl 1):142-151. doi: 10.1111/j.1360-0443.2006. 01591.x.
  30. Potenza MN, Koran LM, Pallanti S. The relationship between impulse-control disorders and obsessive-compulsive disorder: a current understanding and future research directions. Psychiatry Res.2009;170(1):22-31. doi: 10.1016/j.psychres.2008.06.036.
  31. Tavares H, Gentil V. Pathological gambling and obsessive-compulsive disorder: towards a spectrum of disorders of volition. Rev Bras Psiquiatr. 2007;29(2):107-117. doi: 10.1590/S1516-44462007000200005.
  32. Tissen IY, Vinogradov PM, Khokhlov PP, et al. Orexin receptor type 1 (OX1R) are involved in the formation and reinstatement of conditioned plaice preference. Eur Neuropsychopharmacol. 2015;25 (Suppl 2):269-270. doi: 10.1016/S0924-977X(15)30313-8.
  33. Thomas A, Burant A, Buiр N, et al. Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety. Psychopharmacology (Berl). 2009; 204(2):361-373. doi: 10.1007/s00213-009-1466-y.
  34. Shabanov PD, Lebedev AA. Involvement of GABA- and dophaminergic mechanisms of the bed nucleus of the stria terminalis in the reinforcing effects of psychotropic substances mediated via the lateral hypothalamus. Neurosci Behav Physiol. 2013;43(4):485-491. doi: 10.1007/s11055-013-9759-3.
  35. Shabanov PD, Lebedev AA, Bychkov ER. Influences of intrauterine ethanol on the maturation of the monoaminergic systems in the developing rat brain. Neurosci Behav Physiol. 2013;43(8):951-956. doi: 10.1007/s11055-013-9834-9.
  36. Veale D, Roberts A. Obsessive-compulsive disorder. Biomed J. 2014;348:2183. doi: 10.1136/bmj.g2183. doi: 10.1136/bmj.g2183

Copyright (c) 2016 Shabanov P.D., Lebedev A.A., Yakushina N.D., Pshenichnaya A.G., Bychkov E.R.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 65565 от 04.05.2016 г.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies